The Nasdaq Biotechnology Index rose by 1.3%, temporarily outperforming the three major U.S. stock indices

Wallstreetcn
2025.07.02 14:11

Component stocks Precigen rose 14.48%, Prime Medicine rose 12.28%, Esperion rose 11.00%, Rocket Pharma rose 10.81%, Editas Medicine rose 10.44%. Grail fell 2.11%, Y mAbs Therapeutics fell 2.22%, Fortrea Holdings fell 2.69%, Silence Therapeutics fell 2.79%, Biomea Fusion fell 2.91%, Mesoblast fell 9.16%

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.